Mary Fisher, Chief Operating Officer at ACORDA THERAPEUTICS INC (ACOR), sold 7,500 shares at $20.91 ($157K) on 2007-03-01, disclosed to the SEC on 2007-03-02.
Scheduled sale ($157k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.65 | 400 | $8K | 5.3% |
| 2 | $20.79 | 500 | $10K | 6.6% |
| 3 | $20.82 | 600 | $12K | 7.9% |
| 4 | $20.83 | 200 | $4K | 2.6% |
| 5 | $20.84 | 200 | $4K | 2.7% |
| 6 | $20.87 | 500 |
| $10K |
| 6.6% |
| 7 | $20.88 | 500 | $10K | 6.6% |
| 8 | $20.89 | 700 | $15K | 9.3% |
| 9 | $20.90 | 400 | $8K | 5.3% |
| 10 | $20.91 | 500 | $10K | 6.6% |
| 11 | $20.98 | 300 | $6K | 4.0% |
| 12 | $21.09 | 500 | $11K | 6.7% |
| 13 | $21.13 | 300 | $6K | 4.0% |
| 14 | $21.16 | 400 | $8K | 5.4% |
| 15 | $21.19 | 1,000 | $21K | 13.5% |
| 16 | $21.21 | 500 | $11K | 6.7% |
| Total | $20.96 avg | 7,500 | $157K | 100% |
| Filing → |
| OVAS | BUY | 2015-09-11 | $101K | — | Filing → |
| ZLTQ | SELL | 2015-01-27 | $1.7M | — | Filing → |
| ACOR | SELL | 2007-07-05 | $133K | — | Filing → |